Default company panoramic image
Ff2c4056 0e70 46ef 880e 6325c74ea64f

Innovimmune Biotherapeutics Holding, LLC

IND-enabling development of proprietary best-in-class oral INV-17 ROR gamma modulators & oral INV-88 MIF inhibitors for high-growth Autoimmune Diseases.

  • Stage Product In Development
  • Industry Biotechnology
  • Location NYC, NY, US
  • Currency USD
  • Founded 2010
  • Employees 8
  • Website innovimmune.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.